The American College ofRheumatology 1990 criteia for the classification offibromyalgia*4 1. History ofwidespread pain Definition: Pain is considered widespread when all of the following are present: pain in the left side of the body, pain in the right side of the body, pain above the waist, and pain below the waist. In addition, axial skeletal pain (cervical spine or anterior chest or thoracic spine or low back) must be present.
2. Pain in 11 of 18 tender sites on digital palparion Definition: Pain, on digital palpation, must be present in at least 11 of the following 18 tender point sites:
Occiput: bilateral, at the subocciptal muscle insertions Low cervical: bilateral, at the anterior aspects of the intertransverse spaces at C5-7 Trapezius: bilateral, at the midpoint of the upper border Supraspinatus: bilateral, at origins, above the scapula spine near the medial border Second rib: bilateral, at the second costochondral junctions, just lateral to the junctions on upper surfaces Lateral epicondyle: bilateral, 2 cm distal to the epicondyles Gluteal: bilateral, in upper outer quadrants of buttocks in anterior fold of muscle Greater trochanter: bilateral, posterior to the trochanteric prominence Knee: bilateral, at the medial fat pad proximal to the joint line Digital palpation should be performed with an approximate force of 4 kg. For a tender point to be considered 'positive,' the subject must state that the palpation was painful. 'Tender' is not to be considered painful.
*For purposes of classification, patients will be said to have fibromyalgia if both criteria are satisfied. Widespread pain must have been present for at least three months. The presence of a second clinical disorder does not exclude the diagnosis of fibromyalgia.
of the homogeneity of fibromyalgia has given investigators the opportunity to share observations and develop novel paradigms for understanding chronic musculoskeletal pain. Such research has found no evidence for a primary pathological role of muscle in fibromyalgia.6 Investigators are now focusing on the interactions of abnormal peripheral and central pain mechanisms, in addition to the complicated interactions of sleep, mood disturbances and pain. Preliminary studies of neurohormones, growth hormone, and the hypothalamic-pituitary-adrenal axis have generated exciting new hypotheses suggesting altered stress regulation impacting the central nervous system in fibromyalgia.7-9 Do diagnosis and treatment improve t;u*.-ome? The opponents of the concept of fibromyalgia consider it a 'non-disease' and suggest that the fibromyalgia 'label' is likely to create a population of 'worried well', with dire sociological and psychological consequences.10 The Australian experience with the diagnosis of repetitive strain injury warns us of the possibility of such negative disease labelling." My experience has been that the label of fibromyalgia provides a structure for patient understanding and a model for treatment (figure). Most patients with fibromyalgia have been shuttled back and forth from numerous physicians, and have undergone numerous costly and sometimes dangerous tests and ineffective treatments before the diagnosis; the average duration of symptoms before the diagnosis of fibromyalgia is five years. Once the diagnosis is established, fear of a degenerative disease ends and patient frustration and anger can be channelled into a programme of coping and rehabilitation.
Of course, simply pronouncing that the patient has a diagnosis is ineffective unless a detailed explanation about the condition, its treatment, and prognosis ensues. Patients need to understand that there is no progressive muscle pathology and that avoidance behaviour and physical inactivity is counterproductive in any chronic soft tissue pain disorder, whether idiopathic low back pain or fibromyalgia (figure). Careful discussion of the interplay of soma and psyche should be based on fibromyalgia research in sleep, mood, and potential neurohormonal interactions.
The chronicity of the illness should be addressed, as most studies demonstrate that fibromyalgia is a chronic disorder with few remissions and persistent pain and fatigue.'2 However, most of such longitudinal studies have followed tertiary referral rheumatology patients with coexistent significant psychopathology. In contrast, a recent community based study reported that after two years of treatment, 47% of fibromyalgia patients no longer fulfilled diagnostic criteria and 24% were in remission.'3
Tricyclic medications, such as amitriptyline and cyclobenzaprine, and certain other central nervous system active medications have been more effective than non-steroidal anti-inflammatory medications or placebo in short term controlled clinical trials.'4 However, major clinical improvement has occurred in only about 25% of patients, and appears to lessen over time.'5 Non-medicinal treatments that have shown some efficacy include cardiovascular fitness exercise, regional sympathetic blockade, electroacupuncture, hypnotherapy, electromyographybiofeedback, and cognitive behavioural therapy, including stress reduction, relaxation response training.'6 Multidisciplinary treatment programmes which focus on education, teach the importance of self help, and utilise a team of mental health and physical medicine and rehabilitation specialists, may be cost effective in fibromyalgia patients with the greatest levels of pain and disability.
Without such educational approaches and comprehensive pain management, fibromyalgia can indeed be a disabling disorder. In many countries, fibromyalgia is a common cause of being categorised as unfit for work and an increasing cause of litigation and compensation.
However, this is not a consequence of the fibromyalgia label but rather a consequence of the focus by society on entitlement and the medical professions' inability to deal effectively with chronic physical and psychological pain. 7 18 Current and future recommendations
The controversy over fibromyalgia has been fuelled by the increasing recognition of this clinical disorder. Opponents of the fibromyalgia concept suggest that fibromyalgia terminology and diagnostic criteria are flawed. Indeed, we do not know how to classify patients who hurt all over, patients who do not have at least 1 1 ofthe 18 tender points, those with secondary gain from their illness, and those with coexistent major mood disturbances. Yet, we at least have a common illness in mind when sharing observations and research studies from around the world.
Opponents of the fibromyalgia concept argue that, as it is a non-disease, we are legitimising patients' sickness behaviour by providing a disease label. I would argue that unhappiness in work, psychosocial issues, and inherent personality traits, not disease labels and diagnostic terms, promote disability. Furthermore, many of the patients with what we now call fibromyalgia have suffered through numerous medical and surgical misdiagnoses and ineffective treatments, driving them further to despair and depression. The label of fibromyalgia, put in its proper perspective, provides a health care professional with the basis to recommend activity, rather than inactivity, work modification, rather than work termination, and coping rather than catastrophising.
In conclusion, the clinical syndrome that we now recognise as fibromyalgia has been with us for centuries and is here to stay. In common with other similar poorly understood syndromes, including migraine, irritable bowel, and depression, failure of the patient to fulfil Koch's postulates and the absence of objective physical and laboratory abnormalities does not mean that the patient is not ill or in distress. We must accept that some patients' physical and emotional pain may be 'disabling.' In a nonjudgmental fashion we must steer them away from sickness behaviour. Rather than worrying about the best label or set of diagnostic criteria for fibromyalgia and related syndromes, we need to focus on the complicated psychosocial and biological factors that distinguish individuals who cope very well with these symptoms and move ahead with their lives, in contrast to those who are mired in the depths of chronic pain.
